2023-11-20 06:08:00
Sanofi’s Dépakine, the antiepileptic drug and new complaints from families
And antiepileptic drug, already the subject of investigations and trials, has once again come under fire. It’s about Dépakine produced by the French Sanofi. The company was indicted in 2020 for “aggravated deception” and “involuntary injury”. Now the families of some children are breaking the silence and new accusations are pouring in. The mother of two autistic children – we read in Le Monde – has filed a complaint for endangering others. You have never taken Dépakine, this antiepileptic drug responsible for malformations e disorders in children exposed in utero, but it was exposed to emissions into the atmosphere. The Dépakine scandal perhaps did not reveal all its secrets, nor did it reveal all its victims. The antiepileptic drug marketed since 1967 by the Sanofi laboratory is responsible for malformations and neurodevelopmental disorders in thousands of children of mothers treated during pregnancy.
Read also: Giulia murder, here’s why bringing mental health back to the centre. Analyses
Read also: Elections, Sardinia to FdI. Basilicata at the League with Pepe. Exclusive
Read also: Fininvest, green light for social agreements. The post-Sylvian empire takes shape
According to the testimonials collected by Le Monde, similar pathologies would be present in the children of residents who live near the factory that produces Dépakine, in Mourenx (Pyrenees-Atlantiques), and in the workers who frequent the industrial area. None of the mothers took the drugeveryone wonders about the binding to sodium release, its active ingredient, in the air around the premises. This is the case of Mélanie S. (who wishes to remain anonymous), whose two children have neurodevelopmental disorders similar to those observed in children exposed in utero to Dépakine. After years of hesitation, the diagnosis of autism of her daughter in July, after that of her son three years earlier, made her decide to take legal action.
Subscribe to the newsletter
#Sanofis #Dépakine #malformations #accusations #antiepileptic #drug